Ongoing Exposure of U.K. Infants to Vaccine Serotype Pneumococci
Pediatr Infect Dis J
.
2019 Apr;38(4):444.
doi: 10.1097/INF.0000000000002184.
Authors
Mary Slack
1
,
Andrew Vyse
,
Harish Madhava
,
Ralf-Rene Reinert
,
Gillian Ellsbury
,
Carole Czudek
,
Bradford Gessner
Affiliation
1
School of Medicine, Griffith University, Gold Coast Campus, Qld 4222, Australia Pfizer Ltd, Walton Oaks, United Kingdom Pfizer Inc, Paris, France Pfizer Ltd, Walton Oaks, United Kingdom Pfizer Vaccines, Collegeville, PA.
PMID:
30882750
DOI:
10.1097/INF.0000000000002184
No abstract available
Publication types
Letter
Comment
MeSH terms
Child
England
Humans
Infant
Pneumococcal Infections*
Pneumococcal Vaccines
Serogroup
Streptococcus pneumoniae / immunology*
Vaccines, Conjugate
Wales
Substances
Pneumococcal Vaccines
Vaccines, Conjugate